logo

For the Inventor, By the Inventor

Bridgewater, NJ, United States of America

Dr. Reddy's Laboratories, Incorporated


USPTO Granted Patents = 187



Trademarks = 37

Forward Citations = 351

Loading Chart...
Loading Chart...

479 inventors (with patents filed for the assignee):

goldMedal Javed Iqbal (20 out of 16 patents)

silverMedal Manne Satyanarayana Reddy (18 out of 24 patents)

bronzeMedal Ranjan Chakrabarti (17 out of 35 patents)

4.  Rajeev Singh Raghuvanshi (14 out of 20 patents)

5.  Pradip Kumar Sasmal (14 out of 13 patents)

6.  Rajagopalan Ramanujam (14 out of 37 patents)

7.  Shanavas Alikunju (13 out of 10 patents)

8.  Bijay Kumar Padhi (12 out of 15 patents)

9.  Ashok Tehim (12 out of 71 patents)

10.  Vishweshwar Peddy (11 out of 11 patents)

11.  Sateesh Kandavilli (11 out of 17 patents)

12.  Venkateswarlu Akella (11 out of 15 patents)

13.  Braj Bhushan Lohray (10 out of 37 patents)

14.  Vidya Bhushan Lohray (10 out of 36 patents)

15.  Ish Khanna (9 out of 16 patents)


Core Competencies:
Therapeutic Antibody
Fusion Protein Formulation
Liquid Pharmaceutical Composition
Inflammatory Skin Conditions
Solid Dispersions
Polymorphs and Co-Crystals
Topical Retinoid Compositions
Oral Composition
Glycoprotein Composition
Kappa Opioid Receptor Agonists
Celecoxib Formulations
Auto-Injector Technology

187 patents:

1. 12433947 - Stable formulations of therapeutic antibody (2025-10-07),
2. 12428464 - Stable fusion protein formulation (2025-09-30),
3. 12030948 - Antibody formulation (2024-07-09),
4. 12024561 - Stable antibody formulation (2024-07-02),
5. 11639391 - Stable liquid pharmaceutical composition (2023-05-02),
6. 11390583 - Process for preparation of Siponimod, its salts and solid state forms thereof (2022-07-19),
7. 11382923 - Stable liquid formulations of cyclophosphamide and processes to prepare the same (2022-07-12),
8. 11364212 - Methods for treating inflammatory skin conditions (2022-06-21),
9. 11292793 - Solid dispersions of amorphous Lumateperone p-Tosylate (2022-04-05),
10. 11191740 - Methods for treating inflammatory skin conditions (2021-12-07),
11. 11168107 - Amine salt of obeticholic acid (2021-11-09),
12. 11168057 - Polymorphs and co-crystals of roxadustat (2021-11-09),
13. 11103517 - Pharmaceutical compositions for minocycline (2021-08-31),
14. 11084791 - Solid state forms of Lenvatinib Mesylate (2021-08-10),
15. 11059799 - Process for preparation of eribulin and intermediates thereof (2021-07-13),
Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in India. It specializes in the development, manufacture, and marketing of generic drugs. With a presence in over 100 countries, Dr. Reddy's aims to provide affordable and innovative healthcare solutions. The company focuses on various therapeutic areas, including oncology, cardiovascular, anti-infective, and more. Dr. Reddy's Laboratories is committed to improving access to quality medicines globally.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
187 Patents

#6 in Bridgewater, NJ

#98 in New Jersey

#2,112 in US

#4,365 in the World

...
Bridgewater, NJ, United States of America

Dr. Reddy's Laboratories, Incorporated

Forward Citations = 351

479 inventors:

goldMedal Javed Iqbal (20 out of 16 patents)

silverMedal Manne Satyanarayana Reddy (18 out of 24 patents)

bronzeMedal Ranjan Chakrabarti (17 out of 35 patents)

4.  Rajeev Singh Raghuvanshi (14 out of 20 patents)

5.  Pradip Kumar Sasmal (14 out of 13 patents)

Please report any incorrect information to support@idiyas.com
Loading…